Jump to content

Yield10 Bioscience

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Keitsist (talk | contribs) at 17:26, 30 September 2012 (added image, cats, stub tag). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Metabolix, Inc.
File:Metabolix Logo.jpg
Traded as	MBLX
Revenue	US$1,425,000 (2011) US$448,000 (2010)
Operating income	US$-38,861,000 (2011) US$-38,939,000 (2010)
Net income	US$-38,785,000 (2011) US$-38,803,000 (2010)
Website	www.yield10bio.com

This article or section is in a state of significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. If this article or section has not been edited in several days, please remove this template.
If you are the editor who added this template and you are actively editing, please be sure to replace this template with {{in use}} during the active editing session. Click on the link for template parameters to use. This article was last edited by Keitsist (talk | contribs) 12 years ago. (Update timer)

Metabolix is a bioplastics technology development and commercialization company. It is a spinoff of the University of Massachusetts Lowell

Notes

References

External links

This corporation or company article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Yield10_Bioscience&oldid=515337940"

Hidden categories: